Abstract: Novel compounds of the formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof are described. These novel compounds can inhibit HDAC's and are useful as a therapeutic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, autoimmune diseases, skin diseases, i};fections, inflammation, cancer, psoriasis, proliferative conditions and conditions mediated by HDAC.
Novel compounds of the formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof are described. These novel compounds can inhibit HDAC's and are useful as a therapeutic or ameliorating agent for diseases that are involved in cellular growth such as malignant tumors, autoimmune diseases, skin diseases, i};fections, inflammation, cancer, psoriasis, proliferative conditions and conditions mediated by HDAC.
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 92-che-2007abs image.jpg | 2011-09-02 |
| 1 | 92-CHE-2007_EXAMREPORT.pdf | 2016-07-02 |
| 2 | 92-CHE-2007 AMENDED PAGES OF SPECIFICATION 08-11-2013.pdf | 2013-11-08 |
| 2 | 92-che-2007-form 1.pdf | 2011-09-02 |
| 3 | 92-che-2007-description(provisional).pdf | 2011-09-02 |
| 3 | 92-CHE-2007 CORRESPONDENCE OTHERS 08-11-2013.pdf | 2013-11-08 |
| 4 | 92-che-2007-correspondnece-others.pdf | 2011-09-02 |
| 4 | 92-CHE-2007 AMENDED PAGES OF SPECIFICATION 08-02-2013.pdf | 2013-02-08 |
| 5 | 92-che-2007-abstract.pdf | 2011-09-02 |
| 5 | 92-CHE-2007 AMENDED CLAIMS 08-02-2013.pdf | 2013-02-08 |
| 6 | 92-che-2007 form-3.pdf | 2011-09-02 |
| 6 | 92-CHE-2007 FORM-3 08-02-2013.pdf | 2013-02-08 |
| 7 | 92-che-2007 correspondence-others.pdf | 2011-09-02 |
| 7 | 92-CHE-2007 EXAMINATION REPORT REPLY RECEIVED 08-02-2013.pdf | 2013-02-08 |
| 8 | 92-CHE-2007 FORM-5.pdf | 2012-03-17 |
| 8 | 92-CHE-2007 ABSTRACT.pdf | 2012-03-17 |
| 9 | 92-CHE-2007 CLAIMS.pdf | 2012-03-17 |
| 9 | 92-CHE-2007 FORM-3.pdf | 2012-03-17 |
| 10 | 92-CHE-2007 CORRESPONDENCE OTHERS.pdf | 2012-03-17 |
| 10 | 92-CHE-2007 FORM-18.pdf | 2012-03-17 |
| 11 | 92-CHE-2007 DESCRIPTION (COMPLETE).pdf | 2012-03-17 |
| 12 | 92-CHE-2007 CORRESPONDENCE OTHERS.pdf | 2012-03-17 |
| 12 | 92-CHE-2007 FORM-18.pdf | 2012-03-17 |
| 13 | 92-CHE-2007 CLAIMS.pdf | 2012-03-17 |
| 13 | 92-CHE-2007 FORM-3.pdf | 2012-03-17 |
| 14 | 92-CHE-2007 ABSTRACT.pdf | 2012-03-17 |
| 14 | 92-CHE-2007 FORM-5.pdf | 2012-03-17 |
| 15 | 92-CHE-2007 EXAMINATION REPORT REPLY RECEIVED 08-02-2013.pdf | 2013-02-08 |
| 15 | 92-che-2007 correspondence-others.pdf | 2011-09-02 |
| 16 | 92-CHE-2007 FORM-3 08-02-2013.pdf | 2013-02-08 |
| 16 | 92-che-2007 form-3.pdf | 2011-09-02 |
| 17 | 92-CHE-2007 AMENDED CLAIMS 08-02-2013.pdf | 2013-02-08 |
| 17 | 92-che-2007-abstract.pdf | 2011-09-02 |
| 18 | 92-CHE-2007 AMENDED PAGES OF SPECIFICATION 08-02-2013.pdf | 2013-02-08 |
| 18 | 92-che-2007-correspondnece-others.pdf | 2011-09-02 |
| 19 | 92-che-2007-description(provisional).pdf | 2011-09-02 |
| 19 | 92-CHE-2007 CORRESPONDENCE OTHERS 08-11-2013.pdf | 2013-11-08 |
| 20 | 92-che-2007-form 1.pdf | 2011-09-02 |
| 20 | 92-CHE-2007 AMENDED PAGES OF SPECIFICATION 08-11-2013.pdf | 2013-11-08 |
| 21 | 92-CHE-2007_EXAMREPORT.pdf | 2016-07-02 |
| 21 | 92-che-2007abs image.jpg | 2011-09-02 |